Skip to main content
Caplight Logo









AkkoLens International

AkkoLens International

Private
RijswijkHealthcare & Life Scienceshttps://www.akkolens.com/

Last Round

VC Round

Feb 14, 2024

Company Overview

AkkoLens International is a medical device company that develops accommodative intraocular lenses for the treatment of cataracts and presbyopia.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Clinical Trials

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

intraocular lensIOLaccommodative lenscataract surgerypremium IOLrefractive surgeryophthalmology devicepresbyopia correctionvision restorationmedical device manufacturerophthalmic surgerymultifocal lens

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

AkkoLens International Comparables

Compare AkkoLens International with similar companies based on industry and business-model similarity.

AkkoLens International comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Swiss Advanced Vision
90%
LensGen
88%
Adaptilens
86%

AkkoLens International Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundFeb 14, 2024
VC RoundFeb 1, 2014
VC RoundMar 1, 2011

Key People

Founding team and executive leadership

Peter Taal

Chief Executive Officer

Executive Team

AkkoLens International Investors

Notable investors and investment history

AkkoLens International investors
InvestorRounds
Brabantse Ontwikkelings MaatschappijVC Round
MedSciences CapitalVC Round
Particon B.V.VC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 10, 2025

    Monthly visitors grew 121% MoM, reaching 2.1K.

  • Feb 14, 2024

    Raised $7.56M in a venture round.

AkkoLens International Filings

Explore SEC and related filing metadata, where available.

AkkoLens International filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about AkkoLens International's valuation, stock price, and market status.

Is AkkoLens International a public or private company?

AkkoLens International is a private company.

What is the current stock price of AkkoLens International?

AkkoLens International is a private company with no public stock price. No recent secondary market data is available.

How much is AkkoLens International worth (valuation)?

Valuation information for AkkoLens International is not publicly available.

Can I buy AkkoLens International stock?

AkkoLens International shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was AkkoLens International's last funding round?

AkkoLens International's most recent funding round was VC Round on February 14, 2024.

Who are the main investors in AkkoLens International?

Key investors in AkkoLens International include Brabantse Ontwikkelings Maatschappij, MedSciences Capital, Particon B.V..

Will AkkoLens International IPO soon?

No public IPO plans have been announced for AkkoLens International.

How can I track AkkoLens International secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor AkkoLens International's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersRijswijk
Employee Range5
Year Founded2005
Last FundingFeb 14, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?